Navigation Links
Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
Date:8/7/2009

ce they are developed."

McEnany concluded, "Catalyst, along with leading addiction clinicians across the U.S., continues to seek governmental grants from the National Institutes of Health ("NIH"), the National Institute on Drug Abuse, and other agencies that operate under the NIH umbrella, for future vigabatrin addiction trials and to provide a portion of the required funding for our future clinical and non-clinical trials."

Publication of Phase II Mexican Cocaine Trial Results

A paper describing the positive results obtained in an investigator-initiated Phase II trial conducted in Mexico in 2007 was published on August 3, 2009 in the online edition of The American Journal of Psychiatry, a world leading peer-reviewed medical journal. The paper, entitled "Randomized, Double-Blind, Placebo-Controlled Trial of Vigabatrin for the Treatment of Cocaine Dependence in Mexican Parolees," was authored by Jonathan D. Brodie, M.D., Ph.D., Brady G. Case, M.D., Emilia Figueroa, M.D., Stephen L. Dewey, Ph.D., James A. Robinson, M.Ed., Joseph A. Wanderling, M.A. and Eugene M. Laska, Ph.D. The paper suggests that vigabatrin may be effective in the treatment of cocaine addiction. An abstract of the paper can be accessed by clicking here.

"We are extremely pleased that the results of this important trial have been published by a medical journal of this caliber," commented Mr. McEnany. "Catalyst is pleased to have provided financial support for this trial."

About Catalyst Pharmaceutical Partners

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Using catalysts to stamp nanopatterns without ink
2. Experiments reveal unexpected activity of fuel cell catalysts
3. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
4. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
5. Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement
6. Controlling the size of nanoclusters: First step in making new catalysts
7. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
8. NIST and partners identify tiny gold clusters as top-notch catalysts
9. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
10. Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
11. PointCross Releases Catalyst for Building Business-Ready SharePoint Solutions in 1/10th the Time

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...and,November24/PRNewswire-FirstCall/--deCODE,genet...ivednoticefrom,theNasdaqStockMarketthattradinginth...0,2009andaForm25-NSEwillbefiledwiththe,Securitiesa...stock,fromlistingonNasdaq,unlessthecompanyfilesana...panyhasfiledsuchanappeal,which,willstaythesuspensi...
(Date:11/24/2009)...and,November24/PRNewswire-FirstCall/--deCODE,genet...allofits,"firstday"motionsbytheU.S.BankruptcyCourt...CODElastweekfiledavoluntarypetitionfor,reliefunder...nkruptcyCourt. , TheordersissuedbytheBankrupt...essduringtheChapter11proceedings.Inparticular,the,...
(Date:11/24/2009)...4/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Ch...ovedthe,investigationalnewdrugapplication(IND)fori...ormulationtotreatdiabetes.ThisIND,approvalallowsBi... Diabetesisadisordercharacteristicofhighbloodgluco...enresultinseveremicro-and,macro-vasculardiseases,l...
(Date:11/24/2009)...yendpointhasbeenmetforpatientswithadvanced-stage,o....24/PRNewswire-FirstCall/-AEternaZentarisInc.(NASD...euticalcompanyfocusedonendocrinetherapyandoncology...ywithitstargetedcytotoxicpeptideconjugate,AEZS-108...endometrialcancer.Inapersonalizedhealthcareapproac...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...oy, N.Y. Researchers at Rensselaer Polytechnic In...nexpensive, quick-drying polymer that could lead t...miconductor manufacturing and computer chip packag...nd cost savings for conventional photolithography ...siloxane (PES), should also enable a new generatio...
...E, Jan. 28 Cell Therapeutics, Inc.,(CTI) (Nasdaq ...g today,shareholders approved the proxy proposal a...corporation to increase the number of authorized,s...ase the number of,authorized shares of common stoc...co, Chief Financial Officer at CTI, who chaired th...
...ON, Jan. 28 /PRNewswire-FirstCall/ - Quest PharmaT...d that it has signed a,collaborative research agre...velop a combination therapy for the treatment of l...he Company,s lead oncology product,SL052, with var...that,photodynamic therapy (PDT) can augment the th...
Other Biology Technology:New polymer could improve semiconductor manufacturing, packaging 2Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 3
(Date:11/24/2009)...lable in Spanish . , The presence of increa...mmatory substances in the blood, hinders the loss ...arch project of the University of Navarra conducte...School of Pharmacy. , The project, entitled "A n...the control of body weight and inflammation," exam...
(Date:11/23/2009)... community-associated strain of the deadly superbu...ost common antibioticsposes a far greater health t...into hospitals, according to a study in the Decemb...he new threat is easily picked up in fitness cente...ased the overall burden of MRSA within hospitals, ...
(Date:11/23/2009)...3, 2009 - The time of day matters to forest trees ...duced by a research team led by Professor Malcolm ...-principal for research and colleagues in the depa...ge campus. , Capitalizing on their previous wo...search team examined how poplar trees use their 45...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 1Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 3Lower Drinking Age Linked to Later Life Problems 57675 1Lower Drinking Age Linked to Later Life Problems 57675 2Lower Drinking Age Linked to Later Life Problems 57675 3Cybernetwork to help K State researchers study tallgrass prairie respond to global warming 9982 1Cybernetwork to help K State researchers study tallgrass prairie respond to global warming 9982 2
...The Stowers Institutes Trainor Lab has demonstrate...velopment of the nervous system, a process that re... neural cells with the cycle of cell division that...s regulating these distinct cellular activities ha...be published in the Feb. 15 issue of Development. ...
...MADISON, WI, January 28, 2008 -- As organic farmin...n the industry are increasingly important. In a re...ientists successfully use nitrogen isotopic discri...rtilizers were used on sweet pepper plants. , Sci...y Desarrollo Agrario y Agrario y Alimentario (IMID...
... Virginia Key, Fla.-- The University of Miamis Ros...nnounced today that it has selected Dennis J. McGi...enstiel Award. McGillicuddy, a senior scientist in...eering at the Woods Hole Oceanographic Institution...study of physical-biological interactions in the o...
Other Biology News:Trainor Lab characterizes gene essential for prenatal development of nervous system 2Is it organic or not? 2Oceanographer Dennis J. McGillicuddy, Jr. receives 34th annual Rosenstiel Award 2
Mouse Anti-Mouse Qa-2 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone 695H1-9-9 from BioLegend
27-mer duplex from B-Bridge International
Propidium Iodide Buffer from BioLegend
Luminex 100 Instrument System from Upstate
Biology Products: